Searched for
ZANDU CHEMICALS
These 6 midcap stocks with ‘strong buy’ & ‘buy’ ratings can rally over 25%, say analystsFor all those who are busy guessing how things will pan out for markets in the short term due to evolving news flow. A small reminder, ever...
These 8 midcap stocks with ‘strong buy’ & ‘buy’ ratings can rally over 25% during volatile Q3 earnings seasonIn earning seasons equity markets tend to be volatile. Especially at the time when large companies are announcing their quarterly results, ...
These midcaps with ‘strong buy’ and ‘buy’ ratings have upside potential of more than 25%In volatile markets, where stocks across sectors are coming under pressure, there are stocks which were analyst are positive projected retu...
ED probing at least 10 crypto exchanges; fintech firms want clarity on new lending rulesThe Enforcement Directorate (ED) is probing at least 10 crypto currency exchanges for allegedly laundering more than Rs 1,000 crore identif...
Zandu scion Nihar Parikh sets up a family office for healthcare bets4Point0 Health Ventures will deploy about $75 million into the sector and will cut $1-2 million cheques.
Two Mumbai-based family offices in talks to invest in IPO-bound Ola Mobility“Ola Mobility is in discussion with several family offices including Parikh Family and Taparia Family apart from IIFL Wealth Management and...
Bought for Rs 12.5 cr, sold at Rs 2000 cr; How Zandu scion scaled API business 160 times in 12 yearsNihar Parikh has sold 100% of ZCL, an API co to Advent International riding the industry upswing after turning around a once-sub scale oper...
PE firm Advent to buy controlling stake in ZCL Chemicals for Rs 1,700 croreZCL manufactures specialty active pharmaceutical ingredients (APIs) and advanced intermediates, with a focus on niche therapeutic areas and...
PE fund Advent International to buy ZCL ChemicalsAdvent will buy about 51% stake in ZCL at an enterprise value of Rs1700 crore, said sources in the know. With this transaction, existing in...
FSSAI considering new regulations for honey; standards keep evolving, says CEOLast week, the Centre for Science and Environment (CSE) named 10 leading Indian brands of honey as adulterated with sugar. The CSE report s...
FSSAI seeks details of CSE tests on honey; questions body for not conducting SMR testStating that it has taken note of the CSE investigation on adulteration in honey, FSSAI said it had already made SMR test mandatory as it i...
Market Now: Over 50 stocks hit fresh 52-week highsOverall, 8 shares were trading in green in Nifty50 index, while 42 were trading in red around 10.50 am (IST).
Morgan Stanley PE Asia buys 20% in ZCL for Rs 170 croreThe capital, raised from the private equity arm of global financial services company Morgan Stanley, will be used to fund the company’s gro...
ZCL raises Rupees 170 cr from Morgan Stanley PEZCL said it is a speciality pharma company focusing on niche therapeutic areas of central nervous system (CNS), anti-retroviral (ARV) and c...
Morgan Stanley to purchase 20% stake in ZCL Chemicals for Rs 180 croreNihar Parikh, executive director of ZCL, declined to comment on the fund raising and stake sale plans of the company.
Patanjali to launch more dairy items,enter cattle feed segment"We are coming out with cattle feed without any urea in it which will be beneficial for cattle," Ramdev said.
Kedaara Capital set to buy 20% stake in ZCL Chemicals for about Rs 180 croreKedaara Capital is close to picking up around 20 per cent stake in ZCL Chemicals Ltd, formerly known as Zandu Chemicals.
- One in six firms bucked slowdown till third quarter
The study showed that 70 firms managed to accelerate their net profit growth rate during the nine months to end-December 2008.
- Stocks to watch: RIL, ONGC, M&M, Tata Power
Equities are seen rangebound amid mixed global cues and ahead of the June series derivatives expiry. Crude oil’s relentless rise will conti...
- Stocks to watch: Sterlite, Crompton Greaves, Emami, L&T
The market is likely to remain rangebound with a negative bias on Monday tracking flat global cues. Investors are likely to remain cautious...